Mequitazine is a histamine H1 antagonist (antihistamine). It competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. It provides... It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.
- Mechanism
- Curator reviewed
Mequitazine binds to the histamine H1 receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.
- Primary indication
- For the treatment of Hay fever, urticaria (hives) and allergic rhinitisCurator reviewed
- Formula / weight
- C20H22N2S · 322.467 g/mol (avg)
Resolves to
HOKDBMAJZXIPGC-UHFFFAOYSA-NSMILESC(C1CN2CCC1CC2)N1C2=CC=CC=C2SC2=CC=CC=C12What you can answer from here — as of September 23, 2026
Which drugs share a target with Mequitazine, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account